colistimethate sodium

colistimethate sodium (COLOBREATHE) is an FDA-listed pharmaceutical active ingredient. Associated with Essential Pharma Limited. Route of administration: injection. Current US regulatory status: approved.

COLOBREATHE is a marketed brand name for colistimethate sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

colistimethate sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.